CLINICAL_TRIALS
trial_result
· 2026-04-23
Clinical Trial Update: A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) [Phase 3]
Summary
A Phase 3 study (STEP UP) evaluating semaglutide for weight loss in adults with obesity has completed, and results were posted on 2026-04-23.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2026-04-23